Tenenbaum Fabian 4
4 · Bellerophon Therapeutics, Inc. · Filed May 22, 2019
Insider Transaction Report
Form 4
Tenenbaum Fabian
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2019-05-21$0.59/sh+5,000$2,975→ 484,282 total
Signature
/s/ Fabian Tenenbaum|2019-05-22